UTHR presentation today at Oppenheimer extensively covered MNKD's technosphere | MNKD Message Board Posts

MannKind Corporation

  MNKD website
  • Here We Go Again: Apparently, it's just one of those years. We here in the Greater New Orleans Area now find ourselves "in the cone" for the 7th time this year. And while we more or less dodged bullets the first 6 times, it looks like this time Zeta is going to hit close enough to do damage. We can only hope it stays a relatively minor Cat 1 & weakens upon approach. But preparations are once again in order for those of us living along the central Gulf Coast. Members with family or other interests in the affected area are welcome to post on the new Hurricane Zeta Self-Help board we just set up. Good luck & stay safe! 

MNKD   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  17323 of 17363  at  9/24/2020 8:04:55 AM  by

techstockguru_2000


Re: UTHR presentation today at Oppenheimer extensively covered MNKD's technosphere


MNKD update after again listening to the UTHR presentation and running the numbers. Remember we will also be doing at least $70M next year in Afrezza.

The stock has made several moves over $2, but always pulls back. Unfortunately speculative stocks don't do well when the market is teetering on the edge.

MNKD has presented at 3 different conferences in the last two weeks and their partner UTHR presented yesterday. UTHR praised extensively the technosphere inhaler from MNKD and will use it for hypertension and COPD drugs that they have already approved. These drugs are being trialed and moved from a nebulizer to the MNKD inhaler. Based on projected sales the royalties to MNKD will be $200M-$400M annually. UTHR also mentioned other pulmonary drugs that could use MNKD's inhaler.

MNKD has recently hired several executives from Medtronic's who worked with their closed loop insulin system. The rumor is Medtronic's will take a stake in MNKD for Afrezza their dry powdered inhaled insulin. Ironically UTHR's presentation yesterday mentioned a future partnership with Medtronic.

To me the revenue and entire story is finally coming together. Two big partners and now 3 drugs with more to come on the technosphere inhaler from MNKD. I still think I retire on this stock. Buyer beware I've been pumping this sucker on this board for at least 3 years. Lol



     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 2     Views: 175
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
17324 Re: UTHR presentation today at Oppenheimer extensively covered MNKD's technosphere UMD86 0 9/24/2020 9:37:27 AM






Financial Market Data provided by
.
Loading...